CCNG1 | OmnibusX

I. Expression across cell types

Name	Number of supported studies	Average coverage
CD4-positive, alpha-beta T cell	18 studies	20% ± 4%	Explore
fibroblast	14 studies	26% ± 7%	Explore
B cell	13 studies	22% ± 6%	Explore
regulatory T cell	13 studies	20% ± 4%	Explore
natural killer cell	11 studies	18% ± 2%	Explore
naive thymus-derived CD4-positive, alpha-beta T cell	10 studies	23% ± 7%	Explore
CD8-positive, alpha-beta T cell	10 studies	19% ± 3%	Explore
epithelial cell	10 studies	39% ± 21%	Explore
memory B cell	10 studies	20% ± 3%	Explore
naive thymus-derived CD8-positive, alpha-beta T cell	9 studies	22% ± 5%	Explore
smooth muscle cell	9 studies	19% ± 3%	Explore
connective tissue cell	8 studies	26% ± 7%	Explore
T cell	8 studies	23% ± 5%	Explore
endothelial cell	8 studies	23% ± 8%	Explore
epithelial cell of proximal tubule	7 studies	30% ± 10%	Explore
pericyte	7 studies	21% ± 7%	Explore
hematopoietic stem cell	7 studies	31% ± 8%	Explore
gamma-delta T cell	7 studies	23% ± 10%	Explore
myofibroblast cell	6 studies	19% ± 3%	Explore
progenitor cell	6 studies	35% ± 15%	Explore
enterocyte	6 studies	27% ± 11%	Explore
mucosal invariant T cell	6 studies	19% ± 4%	Explore
platelet	6 studies	23% ± 8%	Explore
CD8-positive, alpha-beta memory T cell	6 studies	21% ± 5%	Explore
CD4-positive, alpha-beta memory T cell	6 studies	22% ± 4%	Explore
intestinal crypt stem cell	5 studies	29% ± 7%	Explore
naive B cell	5 studies	20% ± 2%	Explore
transit amplifying cell	5 studies	20% ± 5%	Explore
basal cell	5 studies	25% ± 12%	Explore
effector CD4-positive, alpha-beta T cell	5 studies	23% ± 4%	Explore
T follicular helper cell	5 studies	19% ± 3%	Explore
hematopoietic precursor cell	4 studies	30% ± 10%	Explore
goblet cell	4 studies	28% ± 13%	Explore
mesothelial cell	4 studies	29% ± 19%	Explore
abnormal cell	4 studies	27% ± 6%	Explore
CD16-positive, CD56-dim natural killer cell, human	4 studies	19% ± 2%	Explore
effector CD8-positive, alpha-beta T cell	4 studies	18% ± 1%	Explore
dendritic cell	4 studies	30% ± 13%	Explore
effector memory CD4-positive, alpha-beta T cell	4 studies	19% ± 5%	Explore
mast cell	4 studies	27% ± 9%	Explore
plasmacytoid dendritic cell	4 studies	20% ± 3%	Explore
conventional dendritic cell	3 studies	25% ± 7%	Explore
enteroendocrine cell	3 studies	28% ± 8%	Explore
common myeloid progenitor	3 studies	30% ± 19%	Explore
erythroblast	3 studies	37% ± 14%	Explore
precursor B cell	3 studies	27% ± 8%	Explore
pro-B cell	3 studies	23% ± 2%	Explore
ciliated cell	3 studies	24% ± 7%	Explore
glutamatergic neuron	3 studies	21% ± 3%	Explore
effector memory CD8-positive, alpha-beta T cell	3 studies	20% ± 3%	Explore
granulocyte monocyte progenitor cell	3 studies	19% ± 2%	Explore
megakaryocyte	3 studies	47% ± 9%	Explore
megakaryocyte-erythroid progenitor cell	3 studies	52% ± 18%	Explore
CD16-negative, CD56-bright natural killer cell, human	3 studies	19% ± 3%	Explore
double negative thymocyte	3 studies	29% ± 10%	Explore
luminal hormone-sensing cell of mammary gland	3 studies	21% ± 3%	Explore
secretory cell	3 studies	18% ± 3%	Explore

II. Expression across tissues

Name	Number of supported studies	Average coverage
peripheral blood	10 studies	20% ± 2%	Explore
intestine	6 studies	26% ± 10%	Explore
lung	5 studies	23% ± 8%	Explore
kidney	4 studies	23% ± 2%	Explore
lymph node	3 studies	20% ± 3%	Explore
bone marrow	3 studies	18% ± 1%	Explore
liver	3 studies	30% ± 16%	Explore

Tissue	GTEx Coverage	GTEx Average TPM	GTEx Number of samples	TCGA Coverage	TCGA Average TPM	TCGA Number of samples
prostate	100%	5686.42	245 / 245	100%	204.92	502 / 502
thymus	100%	3824.13	652 / 653	100%	147.76	603 / 605
ovary	100%	7695.25	180 / 180	99%	136.07	427 / 430
liver	100%	3224.85	226 / 226	99%	95.98	403 / 406
intestine	100%	5644.11	966 / 966	99%	113.23	523 / 527
pancreas	99%	6342.16	325 / 328	100%	76.81	178 / 178
esophagus	100%	4380.69	1445 / 1445	99%	70.12	181 / 183
kidney	100%	6384.57	89 / 89	99%	177.88	891 / 901
breast	100%	4900.62	459 / 459	99%	101.11	1105 / 1118
stomach	100%	5278.53	359 / 359	99%	100.45	282 / 286
bladder	100%	6070.10	21 / 21	98%	98.30	494 / 504
adrenal gland	100%	5388.26	258 / 258	98%	103.20	225 / 230
uterus	100%	5098.53	170 / 170	98%	78.81	448 / 459
lung	99%	3813.60	575 / 578	98%	68.81	1133 / 1155
brain	98%	1975.58	2583 / 2642	99%	56.00	698 / 705
skin	99%	5086.88	1796 / 1809	95%	120.51	450 / 472
blood vessel	100%	4683.20	1335 / 1335	0%	0	0 / 0
lymph node	0%	0	0 / 0	100%	117.06	29 / 29
muscle	100%	7173.10	803 / 803	0%	0	0 / 0
spleen	100%	3087.23	241 / 241	0%	0	0 / 0
tonsil	0%	0	0 / 0	100%	62.11	45 / 45
adipose	100%	5213.93	1203 / 1204	0%	0	0 / 0
eye	0%	0	0 / 0	98%	166.37	78 / 80
heart	93%	3080.84	804 / 861	0%	0	0 / 0
peripheral blood	77%	4050.68	713 / 929	0%	0	0 / 0
abdomen	0%	0	0 / 0	0%	0	0 / 0
bone marrow	0%	0	0 / 0	0%	0	0 / 0
diaphragm	0%	0	0 / 0	0%	0	0 / 0
gingiva	0%	0	0 / 0	0%	0	0 / 0
nasal cavity	0%	0	0 / 0	0%	0	0 / 0
nasopharynx	0%	0	0 / 0	0%	0	0 / 0
nose	0%	0	0 / 0	0%	0	0 / 0
placenta	0%	0	0 / 0	0%	0	0 / 0
spinal column	0%	0	0 / 0	0%	0	0 / 0
ureter	0%	0	0 / 0	0%	0	0 / 1

III. Associated gene sets

GO_0000079	Biological process	regulation of cyclin-dependent protein serine/threonine kinase activity
GO_0007095	Biological process	mitotic G2 DNA damage checkpoint signaling
GO_0051301	Biological process	cell division
GO_0043066	Biological process	negative regulation of apoptotic process
GO_0006949	Biological process	syncytium formation
GO_0010243	Biological process	response to organonitrogen compound
GO_0009629	Biological process	response to gravity
GO_0044772	Biological process	mitotic cell cycle phase transition
GO_0000307	Cellular component	cyclin-dependent protein kinase holoenzyme complex
GO_0005654	Cellular component	nucleoplasm
GO_0030425	Cellular component	dendrite
GO_0043025	Cellular component	neuronal cell body
GO_0048471	Cellular component	perinuclear region of cytoplasm
GO_0005737	Cellular component	cytoplasm
GO_0005634	Cellular component	nucleus
GO_0016538	Molecular function	cyclin-dependent protein serine/threonine kinase regulator activity
GO_0005515	Molecular function	protein binding

IV. Literature review

[source]

Gene name	CCNG1
Protein name	Cyclin-G1 (Cyclin-G) Cyclin G1 Cyclin-G1
Synonyms	CCNG CYCG1
Description	FUNCTION: May play a role in growth regulation. Is associated with G2/M phase arrest in response to DNA damage. May be an intermediate by which p53 mediates its role as an inhibitor of cellular proliferation (By similarity). . FUNCTION: May play a role in growth regulation. Is associated with G2/M phase arrest in response to DNA damage. May be an intermediate by which p53 mediates its role as an inhibitor of cellular proliferation. .
Accessions	E7ERZ1 D6RD30 D6RGX3 ENST00000510664.5 ENST00000340828.7 [P51959-1] D6RCC5 ENST00000510097.5 ENST00000504553.2 ENST00000511490.4 P51959 ENST00000512163.5 [P51959-2]

CCNG1 report

I. Expression across cell types

II. Expression across tissues

III. Associated gene sets

IV. Literature review